Vesicle-mediated mitochondrial clearance underlies an actionable metabolic vulnerability in triple-negative breast cancer
Jody Vykoukal, Yihui Chen, Mingxin Zuo, Riccardo Ballarò, M. J. Hong, H. Krishna, Daniela Rodriguez-Perera, Hiroyuki Katayama, Ehsan Irajizad, Ranran Wu, Ricardo A. Léon-Letelier, Jennifer B. Dennison, Angelica M. Gutierrez‐Barrera, Adriana A. Paulucci-Holthauzen, Timothy C. Thompson, , Johannes Francois Fahrmann
The paper identifies a metabolic vulnerability in triple-negative breast cancer through sphingolipid metabolism, showing that targeting this pathway with eliglustat reduces tumor growth and improves survival.
Cell Reports Medicine · Dec 1, 2025Peer-reviewedCancer Biology